India’s weight-loss drug boom and the risks behind it

Written by

admin

in

Soutik BiswasIndia correspondent

Reuters FILE PHOTO: Vials of Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, are seen in a fridge at a health clinic in Hyderabad, India, April 14, 2025. REUTERS/Almaas Masood/File PhotoReuters

India’s anti-obesity drug market has seen a sixfold jump in five years

The calls come thick and fast to Mumbai-based diabetologist Rahul Baxi – but not just from patients struggling to control blood sugar.

Continue Reading

More posts